Is Dominion Energy the Best High-Yield Dividend Stock for You?
https://www.fool.com/investing/2024/08/27/is-dominion-energy-the-best-high-yield-dividend-st/?source=iedfolrf0000001
Aug 27, 2024 - Dominion Energy is a relatively boring utility with a high yield, but there's one important thing it is lacking that will turn some off.
0
Is It Too Late to Buy High-Yield Dominion Energy Stock?
https://www.fool.com/investing/2024/08/25/is-it-too-late-to-buy-high-yield-dominion-energy/?source=iedfolrf0000001
Aug 25, 2024 - Up 15% over the past year, Dominion Energy is in the middle of reshaping its business. There could be plenty of upside from here.
0
Top Stock Reports for Texas Instruments, Union Pacific & Vertex Pharmaceuticals
https://www.zacks.com/commentary/2325736/top-stock-reports-for-texas-instruments-union-pacific-vertex-pharmaceuticals?cid=CS-ZC-FT-research_daily-2325736
Aug 22, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Texas Instruments Incorporated (TXN), Union Pacific Corporation (UNP) and Vertex Pharmaceuticals Incorporated (VRTX), as well as two micro-cap stocks Tile Shop Holdings, Inc. (TTSH) and Gencor Industries, Inc. (GENC).
0
What Is the Dividend Payout for Dominion Energy Stock?
https://www.fool.com/investing/2024/08/21/what-is-the-dividend-payout-for-dominion-energy-st/?source=iedfolrf0000001
Aug 21, 2024 - You can brace for falling interest rates with a stake in Dominion Energy stock.
0
BioMarin appoints new business chief and R&D head
https://seekingalpha.com/news/4142322-biomarin-stock-focus-amid-leadership-shakeup?source=feed_sector_healthcare
Aug 21, 2024 - BioMarin Pharmaceutical announces new leadership appointments in Research & Development and Business Development.
0
D Is For Defense (And Dividends)
https://seekingalpha.com/article/4715184-d-is-for-defense-and-dividends?source=feed_tag_etf_portfolio_strategy
Aug 16, 2024 - Defensive sectors like Utilities, Consumer Staples and Energy are typically more favorable, with dividend-focused funds having performed comparatively better during recent market downturns.
0
Here's What Key Metrics Tell Us About Dominion Energy (D) Q2 Earnings
https://www.zacks.com/stock/news/2315148/here-s-what-key-metrics-tell-us-about-dominion-energy-d-q2-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2315148
Aug 02, 2024 - While the top- and bottom-line numbers for Dominion Energy (D) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Humana, Centene, CVS gain as Medicare releases Part D bid information
https://seekingalpha.com/news/4130476-humana-centene-cvs-gain-medicare-part-d-bid-information?source=feed_sector_healthcare
Jul 30, 2024 - Humana (HUM), Centene (CNC), and CVS Health (CVS) stocks gain as Wall Street reacts to newly-released Medicare Part D bid information for 2025. Read more here.
0
Lilly expecting Q2 IPR&D pre-tax charge of around $0.14 per share: report
https://seekingalpha.com/news/4124073-lilly-expecting-q2-iprd-pre-tax-charge-of-around-014-per-share-report?source=feed_sector_healthcare
Jul 12, 2024 - Eli Lilly (LLY) reportedly expects to record Q2 pre-tax IPR&D charges of around $154M, amounting to approximately $0.14 a share on a GAAP and non-GAAP basis. Read more here.
0
AbbVie names new R&D head
https://seekingalpha.com/news/4123266-abbvie-stock-watch-after-new-rd-head?source=feed_sector_healthcare
Jul 10, 2024 - AbbVie (ABBV) appoints its medical chief Roopal Thakkar as its new Chief Scientific Officer, replacing Thomas Hudson. Read more here.
0